Although cisplatin is an effective chemotherapy drug for the treatment of various cancers, its clinical use is limited due to its side effects, especially nephrotoxicity. Unfortunately, acute kidney injury (AKI) caused by cisplatin remains one of the main challenges in effective cancer treatment. Evidence increasingly suggests that renal inflammation and pyroptotic inflammatory cell death of renal tubular epithelial cells (RTECs) mainly determine the progression and outcome of cisplatin-induced AKI. However, it is not clear how cisplatin regulates the pyroptosis of RTECs cells in AKI. The current study aimed to determine the regulation mechanism of AKI induced by cisplatin. We used cisplatin to induce AKI in vivo. We performed H&E staining of mouse kidney tissue sections and evaluated serological indicators of kidney injury (including blood urea nitrogen (BUN), serum creatinine, and tumor necrosis factor-alpha (TNF-alpha)). We used immunohistochemistry and western blot to detect the important substrate protein gasdermin D (GSDMD) and key target caspase-1 of pyroptosis, respectively. Cisplatin induced mouse AKI and RTECs pyroptosis. HK2 cell-derived exosomes treated with cisplatin influenced pyroptosis of the surrounding HK2 cells. Cisplatin-treated HK2 cells exosome-derived miR-122 regulated pyroptosis in the surrounding cells. Exosome-derived miR-122 affected cisplatin-induced AKI and HK2 cells pyroptosis by regulating the expression of embryonic lethal abnormal vision (ELAVL1). These results suggest that exosome miR-122 inhibited pyroptosis and AKI by targeting ELAVL1 under cisplatin treatment, and this offers a potential target for the treatment of AKI.

Department of Geriatric The 1st Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China

See more in PubMed

Zhang W, Chen C, Jing R, Liu T, Liu B. Remote Ischemic Preconditioning Protects Cisplatin-Induced Acute Kidney Injury through the PTEN/AKT Signaling Pathway. Oxid Med Cell Longev. 2019;2019:7629396. doi: 10.1155/2019/7629396. PubMed DOI PMC

Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994–1007. doi: 10.1038/sj.ki.5002786. PubMed DOI

Dupre TV, Doll MA, Shah PP, et al. Suramin protects from cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol. 2016;310(3):F248–F258. doi: 10.1152/ajprenal.00433.2015. PubMed DOI PMC

Crona DJ, Faso A, Nishijima TF, McGraw KA, Galsky MD, Milowsky MI. A Systematic review of strategies to prevent cisplatin-induced nephrotoxicity. oncologist. 2017;22(5):609–619. doi: 10.1634/theoncologist.2016-0319. PubMed DOI PMC

Holditch SJ, Brown CN, Lombardi AM, Nguyen KN, Edelstein CL. Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury. Int J Mol Sci. 2019;20(12):3011. doi: 10.3390/ijms20123011. PubMed DOI PMC

Mulay SR, Linkermann A, Anders HJ. Necroinflammation in Kidney Disease. J Am Soc Nephrol. 2016;27(1):27–39. doi: 10.1681/ASN.2015040405. PubMed DOI PMC

Weijl NI, Elsendoorn TJ, Lentjes EG, et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study. Eur J Cancer. 2004;40(11):1713–1723. doi: 10.1016/j.ejca.2004.02.029. PubMed DOI

Yang C, Guo Y, Huang TS, et al. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation. Biomed Pharmacother. 2018;107:1354–1362. doi: 10.1016/j.biopha.2018.08.126. PubMed DOI

Place DE, Kanneganti TD. Cell death-mediated cytokine release and its therapeutic implications. J Exp Med. 2019;216(7):1474–1486. doi: 10.1084/jem.20181892. PubMed DOI PMC

Martin SJ. Cell death and inflammation: the case for IL-1 family cytokines as the canonical DAMPs of the immune system. FEBS J. 2016;283(14):2599–2615. doi: 10.1111/febs.13775. PubMed DOI

Zhang Z, Shao X, Jiang N, et al. Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury. Cell Death Dis. 2018;9(10):983. doi: 10.1038/s41419-018-1023-x. PubMed DOI PMC

Ye Z, Zhang L, Li R, et al. Caspase-11 Mediates Pyroptosis of Tubular Epithelial Cells and Septic Acute Kidney Injury. Kidney Blood Press Res. 2019;44(4):465–478. doi: 10.1159/000499685. PubMed DOI

Wang Y, Zhang H, Chen Q, et al. TNF-α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Prolif. 2020;53(6):e12829. doi: 10.1111/cpr.12829. PubMed DOI PMC

Chen F, Lu J, Yang X, et al. Acetylbritannilactone attenuates contrast-induced acute kidney injury through its anti-pyroptosis effects. Biosci Rep. 2020;40(2):BSR20193253. doi: 10.1042/BSR20193253. PubMed DOI PMC

Miao N, Yin F, Xie H, et al. The cleavage of gasdermin D by caspase-11 promotes tubular epithelial cell pyroptosis and urinary IL-18 excretion in acute kidney injury. Kidney Int. 2019;96(5):1105–1120. doi: 10.1016/j.kint.2019.04.035. PubMed DOI

Zhang J, Li S, Li L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13(1):17–24. doi: 10.1016/j.gpb.2015.02.001. PubMed DOI PMC

Qiu G, Zheng G, Ge M, et al. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther. 2018;9(1):320. doi: 10.1186/s13287-018-1069-9. PubMed DOI PMC

Gheinani AH, Vögeli M, Baumgartner U, et al. Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery. Sci Rep. 2018;8(1):3945. doi: 10.1038/s41598-018-22142-x. PubMed DOI PMC

Lv LL, Wu WJ, Feng Y, Li ZL, Tang TT, Liu BC. Therapeutic application of extracellular vesicles in kidney disease: promises and challenges. J Cell Mol Med. 2018;22(2):728–737. doi: 10.1111/jcmm.13407. PubMed DOI PMC

Guan H, Peng R, Mao L, Fang F, Xu B, Chen M. Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes. Exp Cell Res. 2020;392(2):112007. doi: 10.1016/j.yexcr.2020.112007. PubMed DOI

Pan T, Jia P, Chen N, et al. Delayed Remote Ischemic Preconditioning ConfersRenoprotection against Septic Acute Kidney Injury via Exosomal miR-21. Theranostics. 2019;9(2):405–423. doi: 10.7150/thno.29832. PubMed DOI PMC

Meng XM, Ren GL, Gao L, et al. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation. Lab Invest. 2018;98(1):63–78. doi: 10.1038/labinvest.2017.120. PubMed DOI

Zhang R, Yin L, Zhang B, et al. Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death Dis. 2018;9(10):965. doi: 10.1038/s41419-018-0959-1. PubMed DOI PMC

Wu M, Wang Y, Yang D, et al. A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma [published correction appears in EBioMedicine. 2019 May;43:650] [published correction appears in EBioMedicine. 2021;63:103041] EBioMedicine. 2019;41:244–255. doi: 10.1016/j.ebiom.2019.02.012. PubMed DOI PMC

Li ZL, Lv LL, Tang TT, et al. HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammation. Kidney Int. 2019;95(2):388–404. doi: 10.1016/j.kint.2018.09.013. PubMed DOI

Bao H, Zhang Q, Liu X, et al. Lithium targeting of AMPK protects against cisplatin-induced acute kidney injury by enhancing autophagy in renal proximal tubular epithelial cells. FASEB J. 2019;33(12):14370–14381. doi: 10.1096/fj.201901712R. PubMed DOI

Ho J, Kreidberg JA. The long and short of microRNAs in the kidney. J Am Soc Nephrol. 2012;23(3):400–404. doi: 10.1681/ASN.2011080797. PubMed DOI PMC

Lee CG, Kim JG, Kim HJ, et al. Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury. Kidney Int. 2014;86(5):943–953. doi: 10.1038/ki.2014.117. PubMed DOI

Yang Y, Li HY, Zhou Q, et al. Renal Function and All-Cause Mortality Risk Among Cancer Patients. Medicine (Baltimore) 2016;95(20):e3728. doi: 10.1097/MD.0000000000003728. PubMed DOI PMC

Linkermann A, Chen G, Dong G, Kunzendorf U, Krautwald S, Dong Z. Regulated cell death in AKI. J Am Soc Nephrol. 2014;25(12):2689–2701. doi: 10.1681/ASN.2014030262. PubMed DOI PMC

Tonnus W, Gembardt F, Latk M, et al. The clinical relevance of necroinflammation-highlighting the importance of acute kidney injury and the adrenal glands. Cell Death Differ. 2019;26(1):68–82. doi: 10.1038/s41418-018-0193-5. PubMed DOI PMC

Barile L, Vassalli G. Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63–78. doi: 10.1016/j.pharmthera.2017.02.020. PubMed DOI

Zhang W, Zhou X, Zhang H, Yao Q, Liu Y, Dong Z. Extracellular vesicles in diagnosis and therapy of kidney diseases. Am J Physiol Renal Physiol. 2016;311(5):F844–F851. doi: 10.1152/ajprenal.00429.2016. PubMed DOI PMC

Zhu G, Pei L, Lin F, et al. Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p. J Cell Physiol. 2019;234(12):23736–23749. doi: 10.1002/jcp.28941. PubMed DOI

Lv LL, Feng Y, Wu M, et al. Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2020;27(1):210–226. doi: 10.1038/s41418-019-0349-y. PubMed DOI PMC

Cheng Q, Wang L. LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p. Cell Cycle. 2020;19(3):290–299. doi: 10.1080/15384101.2019.1707454. PubMed DOI PMC

Li X, Zeng L, Cao C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res. 2017;350(2):327–335. doi: 10.1016/j.yexcr.2016.12.006. PubMed DOI

Baicalin Ameliorates Cartilage Injury in Rats With Osteoarthritis via Modulating miR-766-3p/AIFM1 Axis